Company Quick10K Filing
Prevail Therapeutics
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 34 $510
10-Q 2019-11-12 Quarter: 2019-09-30
10-Q 2019-08-14 Quarter: 2019-06-30
S-1 2019-05-24 Public Filing
8-K 2020-01-13 Regulation FD, Exhibits
8-K 2020-01-09 Other Events, Exhibits
8-K 2019-12-26 Other Events, Exhibits
8-K 2019-11-15 Officers, Regulation FD, Exhibits
8-K 2019-11-12 Earnings, Exhibits
8-K 2019-10-08 Other Events, Exhibits
8-K 2019-09-10 Other Events, Exhibits
8-K 2019-08-15 Regulation FD
8-K 2019-08-14 Earnings, Exhibits
8-K 2019-06-24 Amend Bylaw, Exhibits

Prevail Therapeutics Financials

PRVL Metrics, Comps, Filings

Annual | Quarterly

Valuation ($)

Market Cap, Enterprise Value

Balance Sheet ($)

Assets, Stockholders' Equity

Income Statement ($ Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($ Annual)

Operating, Investing, Financing

Comps ($ TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Watford Holdings (WTRE) 589,634,272,000 0% 6.0 2% 3,468,528,000,000 2,286,057,000,000 380,818,000,000 0 71,272,000,000 86,395,000,000 520,657,271,000
ETFS Platinum Trust (PPLT) 581,501,000,000 14.2 7% 583,629,000,000 276,000,000 0 0 40,855,000,000 40,855,000,000 581,501,000,000
Cambium Learning (ABCD) 564,574,920,000 76% 24.4 23% 185,293,000,000 185,494,000,000 160,666,000,000 121,379,000,000 43,175,000,000 23,823,000,000 581,876,920,000
Rampart Studios (RMP) 560,672,600,000 0 0 0 0 0 0 560,672,599,000
Milestone Pharmaceuticals (MIST) 553,000,954,000 -18.4 -16% 151,837,000,000 6,524,000,000 0 0 -24,110,000,000 -24,087,000,000 442,176,954,000
Hills Bancorporation (HBIA) 543,353,744,000 3.5 1% 3,263,551,000,000 2,859,802,000,000 0 0 38,269,000,000 83,028,000,000 293,429,743,000
RPX (RPXC) 530,819,520,000 38% 4.1 -15% 564,233,000,000 121,040,000,000 315,066,000,000 120,425,000,000 -85,056,000,000 90,683,000,000 371,599,519,000
CatchMark Timber Trust (CTT) 517,751,800,000 0% -6.2 -24% 730,623,000,000 495,630,000,000 98,737,000,000 0 -178,077,000,000 -158,047,000,000 985,553,800,000
Akero Therapeutics (AKRO) 516,281,252,000 -48.9 -4% 163,168,000,000 4,779,000,000 0 0 -7,228,000,000 -7,228,000,000 353,567,251,000
Livongo Health (LVGO) 514,729,600,000 68% -37.1 -8% 177,209,000,000 49,667,000,000 40,886,000,000 28,003,000,000 -14,244,000,000 -12,810,000,000 475,706,599,000
Matlin & Partners (MPACU) 512,917,871,000 21% 42.6 -13% 701,782,000,000 458,611,000,000 409,627,000,000 86,789,000,000 -91,517,974,000 18,632,630,000 793,404,871,000
Prevail Therapeutics (PRVL) 510,317,910,000 -20.4 -7% 216,078,000,000 15,039,000,000 0 0 -15,103,000,000 -15,103,000,000 308,131,909,000
MariMed (MRMD) 498,253,983,000 48% 57.4 -0% 133,676,476,000 50,851,043,000 32,580,074,000 15,780,892,000 -468,577,000 9,349,695,000 536,320,106,000
First Connecticut Bancorp (FBNK) 493,990,684,000 0% 8.6 1% 3,275,838,000,000 2,993,974,000,000 1,718,000,000 0 18,835,000,000 53,340,000,000 457,022,683,000
Fortune Valley Treasures (FVTI) 492,400,160,000 35% -1,424.5 -72% 476,549,000 1,104,111,000 175,995,000 60,793,000 -343,854,000 -345,612,000 492,312,742,000
AV Homes (AVHI) 489,448,750,000 17% -180.4 -2% 1,024,433,000,000 592,139,000,000 203,560,000,000 35,192,000,000 -24,366,000,000 -4,720,000,000 851,676,750,000
CV Sciences (CVSI) 478,878,840,000 70% -390.8 -4% 52,060,000,000 17,772,000,000 59,589,540,000 41,766,021,000 -1,959,244,000 -1,184,984,000 463,141,839,000
Seven Stars Cloud (SSC) 461,012,321,000 42% 38.5 7% 149,396,651,000 61,176,205,000 100,222,385,000 41,668,212,000 9,833,765,000 12,373,601,000 476,902,510,000
Aegean Marine Petroleum Network (ANW) 451,437,849,000 0% 1,600,933,000,000 1,011,342,000,000 0 0 0 0 929,118,849,000
Perry Ellis (PERY) 436,499,190,000 38% 5.6 9% 554,666,000,000 169,797,000,000 880,665,000,000 332,305,000,000 49,882,000,000 74,302,000,000 415,161,189,000

Balance Sheet ($)
Cash
Accounts Receivable
Inventory
PP&E
Assets
Accounts Payable
Long-Term Debt
Liabilities
Stockholders' Equity
Income Statement ($)
Revenue
Cost of Revenue
Gross Profit
R&D
SG&A
Tax
Net Income
Cash Flow ($)
Cash Operating
Cash Investing
Cash Financing